Tech Company Financing Transactions
OsteoGeneX Funding Round
Kansas Technology Enterprise Corporation participated in a $905 thousand funding round for OsteoGeneX. This VC investment round was announced on 9/30/2010.
Transaction Overview
Company Name
Announced On
9/30/2010
Transaction Type
Venture Equity
Amount
$905,000
Round
Undisclosed
Investors
Kansas Technology Enterprise Corporation (Matthew McClorey)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
11235 Mastin St. 102
Overland Park, KS 66210
USA
Overland Park, KS 66210
USA
Phone
Website
Email Address
Overview
OsteoGeneX is committed to leveraging its innovative signaling pathway technologies to discover and develop small molecule therapeutics that are focused primarily on building new bone.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Debra Ellies
Chief Marketing Officer
William Rosenberg
VP - Bus. Development
Michael Riley
VP - General Counsel
Bruce Jenett
Browse more venture capital transactions:
Prev: 9/30/2010: Offertarget venture capital transaction
Next: 9/30/2010: Eco Power Solutions venture capital transaction
Share this article
Where The Data Comes From
We report on every notable VC transaction. All VC database entries reported here come from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs